mcl 1 overexpression plasmid ptopo mcl Search Results


93
Addgene inc plasmid overexpressing mcl
Plasmid Overexpressing Mcl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/MCL-1(R263A)-GLuc1+(Plasmid+%2388933)/pmc04747351-235-0-6
Average 93 stars, based on 1 article reviews
plasmid overexpressing mcl - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Addgene inc mcl 1 overexpression plasmid ptopo mcl
Mcl 1 Overexpression Plasmid Ptopo Mcl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/pTOPO-MCL1+(Plasmid+%2321605)/10__1158_slash_1541___7786__mcr___18___0650-42-0-8
Average 93 stars, based on 1 article reviews
mcl 1 overexpression plasmid ptopo mcl - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Addgene inc human flag tagged mcl 1 pcdna3 1
Human Flag Tagged Mcl 1 Pcdna3 1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/pcDNA3+Flag+Pu%2E1+(Plasmid+%2366974)/pmc07299726-33-5-16
Average 93 stars, based on 1 article reviews
human flag tagged mcl 1 pcdna3 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Genechem mcl1 overexpression plasmid pcdna- mcl1
FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of <t>pcDNA</t> overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.
Mcl1 Overexpression Plasmid Pcdna Mcl1, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/mcl1+overexpression+plasmid+pcdna++mcl1/pmc09641122-53-30-46
Average 90 stars, based on 1 article reviews
mcl1 overexpression plasmid pcdna- mcl1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
Addgene inc plx307
FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of <t>pcDNA</t> overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.
Plx307, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/pLX307+MCL1+(Plasmid+%23117726)/pm39846250-219-1-13
Average 91 stars, based on 1 article reviews
plx307 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
OriGene mcl 1 overexpression plasmid
FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of <t>pcDNA</t> overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.
Mcl 1 Overexpression Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/MCL1+(NM_021960)+Human+Untagged+Clone/pmc06155218-58-8-12
Average 90 stars, based on 1 article reviews
mcl 1 overexpression plasmid - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
Addgene inc active akt myr akt1 overexpression cells
FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of <t>pcDNA</t> overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.
Active Akt Myr Akt1 Overexpression Cells, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/pLX311+MCL1+(Plasmid+%23117729)/pmc07415806-57-6-15
Average 91 stars, based on 1 article reviews
active akt myr akt1 overexpression cells - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
GenScript corporation mammalian mcl1 overexpression plasmids
Identification of <t>MCL1</t> as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Mammalian Mcl1 Overexpression Plasmids, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/codon+optimized+gene+sequence+encoding+residues+172+327+of+human+mcl+1/pmc07359098-77-0-13
Average 90 stars, based on 1 article reviews
mammalian mcl1 overexpression plasmids - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene vector expressing mcl 1
Identification of <t>MCL1</t> as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Vector Expressing Mcl 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/Mcl1+(NM_008562)+Mouse+Untagged+Clone/pm23199202-59-8-12
Average 90 stars, based on 1 article reviews
vector expressing mcl 1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
OriGene mcl 1 expression plasmid
Identification of <t>MCL1</t> as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Mcl 1 Expression Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/MCL1+(NM_021960)+Human+Tagged+ORF+Clone/pmc06047232-332-11-17
Average 93 stars, based on 1 article reviews
mcl 1 expression plasmid - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
OriGene mcl 1
Identification of <t>MCL1</t> as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Mcl 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/MCL1+(NM_001197320)+Human+Tagged+ORF+Clone+Lentiviral+Particle/pm31384313-77-6-19
Average 90 stars, based on 1 article reviews
mcl 1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene human mcl 1
Identification of <t>MCL1</t> as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Human Mcl 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcl+1+overexpression+plasmid+ptopo+mcl/MCL1+Human+shRNA+Plasmid+Kit/pm26750440-57-4-20
Average 90 stars, based on 1 article reviews
human mcl 1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of pcDNA overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D is highly expressed in tumor tissues and is associated with patient prognosis. (A) The expression of FAM83D was higher in TCGA-LIHC tumor tissues than non-tumor tissues. (B) Data in GEO GSE25097 and GSE76427 show that the level of FAM83D is higher in HCC tissues than non-tumor tissues. (C) The expression of FAM83D in TCGA-LIHC tissues based on tumor grade. (D) The expression of FAM83D in TCGA-LIHC tissues based on individual cancer stages. (E) Patients with high levels of FAM83D had significantly lower overall survival than patients with low levels of FAM83D . (F) FAM83D protein expression in 5 HCC cell lines. (G) The effect of siRNA knockdown on FAM83D in SNU449 cells was verified by Western blotting. (H) The effect of siRNA knockdown on FAM83D in HUH7 cells was verified by Western blotting. (I) The effect of pcDNA overexpress on FAM83D in BEL7402 cells was verified by Western blotting. *P<0.05; **P<0.01. TPM, transcripts per million; TCGA-LIHC, The Cancer Genome Atlas-Liver Hepatocellular Carcinoma; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: Expressing, Knockdown, Western Blot, Gene Expression

FAM83D promotes the proliferation of HCC cells in vitro . (A) MTT assays were used to assess the viability of FAM83D knockdown in HCC cells. (B,C) FAM83D knockdown suppressed the proliferation of SNU449 and HUH7 cells as measured by the EDU analysis (200×). (D) The overexpression of FAM83D promoted the proliferation of BEL7402 cells as measured by the EDU analysis (200×). **P<0.01. HCC, hepatocellular carcinoma; OD, optical density.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D promotes the proliferation of HCC cells in vitro . (A) MTT assays were used to assess the viability of FAM83D knockdown in HCC cells. (B,C) FAM83D knockdown suppressed the proliferation of SNU449 and HUH7 cells as measured by the EDU analysis (200×). (D) The overexpression of FAM83D promoted the proliferation of BEL7402 cells as measured by the EDU analysis (200×). **P<0.01. HCC, hepatocellular carcinoma; OD, optical density.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: In Vitro, Knockdown, Over Expression

FAM83D promotes migration and invasion of HCC cells in vitro . (A) Colony formation experiments of control and FAM83D knockdown and overexpressed HCC cells. Top: representative images; bottom: quantification of colony numbers (crystal violet staining). (B) FAM83D knockdown suppressed SNU449 and HUH7 cell migration ability, and the overexpression of FAM83D promoted BEL7402 cell migration ability as measured by the scratch-healing experiment (40×). (C) Western blot analysis showed that the migration protein level of knocked down FAM83D cells was significantly downregulated, while the migration protein level of over expressed FAM83D cells was significantly upregulated. **P<0.01. HCC, hepatocellular carcinoma.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D promotes migration and invasion of HCC cells in vitro . (A) Colony formation experiments of control and FAM83D knockdown and overexpressed HCC cells. Top: representative images; bottom: quantification of colony numbers (crystal violet staining). (B) FAM83D knockdown suppressed SNU449 and HUH7 cell migration ability, and the overexpression of FAM83D promoted BEL7402 cell migration ability as measured by the scratch-healing experiment (40×). (C) Western blot analysis showed that the migration protein level of knocked down FAM83D cells was significantly downregulated, while the migration protein level of over expressed FAM83D cells was significantly upregulated. **P<0.01. HCC, hepatocellular carcinoma.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: Migration, In Vitro, Control, Knockdown, Staining, Over Expression, Western Blot

FAM83D attenuate the apoptosis of HCC cells in vitro . (A,B) Flow cytometry results showed that FAM83D knockdown promoted cell apoptosis and the apoptotic-related protein level as measured by western blot analysis. (C) Flow cytometry results showed that FAM83D overexpression inhibited cell apoptosis and the apoptotic-related protein level as measured by western blot analysis. **P<0.01. HCC, hepatocellular carcinoma.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D attenuate the apoptosis of HCC cells in vitro . (A,B) Flow cytometry results showed that FAM83D knockdown promoted cell apoptosis and the apoptotic-related protein level as measured by western blot analysis. (C) Flow cytometry results showed that FAM83D overexpression inhibited cell apoptosis and the apoptotic-related protein level as measured by western blot analysis. **P<0.01. HCC, hepatocellular carcinoma.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: In Vitro, Flow Cytometry, Knockdown, Western Blot, Over Expression

FAM83D activates FBXW7 / MCL1 pathway in HCC cells in vitro (HCC cells transfected with FAM83D siRNA; si FAM83D + si FBXW7 ; si FAM83D + pc MCL1 ). (A) The expression levels of FBXW7 and MCL1 proteins in HUH7 and SNU449 cells when FAM83D was knocked down as measured by a western blot analysis. (B) Cell proliferation was measured by MTT assays. (C) Cell migration ability was measured by scratch-healing experiments (40×). **P<0.01; ## P<0.01; HCC, hepatocellular carcinoma; OD, optical density.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D activates FBXW7 / MCL1 pathway in HCC cells in vitro (HCC cells transfected with FAM83D siRNA; si FAM83D + si FBXW7 ; si FAM83D + pc MCL1 ). (A) The expression levels of FBXW7 and MCL1 proteins in HUH7 and SNU449 cells when FAM83D was knocked down as measured by a western blot analysis. (B) Cell proliferation was measured by MTT assays. (C) Cell migration ability was measured by scratch-healing experiments (40×). **P<0.01; ## P<0.01; HCC, hepatocellular carcinoma; OD, optical density.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: In Vitro, Transfection, Expressing, Western Blot, Migration

FAM83D activates FBXW7 / MCL1 pathway in HCC cells in vitro (HCC cells transfected with FAM83D siRNA; si FAM83D + si FBXW7 ; si FAM83D + pc MCL1 ). (A) The migration protein level was measured by western blot analysis. (B) Cell apoptosis was measured by flow cytometry. (C) The apoptotic-related protein level was measured by western blot analysis. **P<0.01; ## P<0.01.

Journal: Translational Cancer Research

Article Title: FAM83D promotes the proliferation and migration of hepatocellular carcinoma cells by inhibiting the FBXW7/MCL1 pathway

doi: 10.21037/tcr-22-2069

Figure Lengend Snippet: FAM83D activates FBXW7 / MCL1 pathway in HCC cells in vitro (HCC cells transfected with FAM83D siRNA; si FAM83D + si FBXW7 ; si FAM83D + pc MCL1 ). (A) The migration protein level was measured by western blot analysis. (B) Cell apoptosis was measured by flow cytometry. (C) The apoptotic-related protein level was measured by western blot analysis. **P<0.01; ## P<0.01.

Article Snippet: FAM83D siRNA (i.e., si FAM83D -1, si FAM83D -2, and si FAM83D -3), FBXW7 siRNA (si FBXW7 ), siRNA negative control (siNC), FAM83D overexpression plasmid pcDNA- FAM83D (pcDNA- FAM83D ), MCL1 overexpression plasmid pcDNA- MCL1 (pcDNA- MCL1 ), and pcDNA negative control (pcDNA-NC) were purchased from Genechem Company (Shanghai, China).

Techniques: In Vitro, Transfection, Migration, Western Blot, Flow Cytometry

Identification of MCL1 as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Journal: Theranostics

Article Title: Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

doi: 10.7150/thno.41802

Figure Lengend Snippet: Identification of MCL1 as a miR-125a/b target. (A) Schematic description of the hypothetical duplex formed by the interactions between the binding site in the MCL1 3'-UTR and miR-125a/b. The miR-125a/b seed sequence and the seed sequence binding sites in the MCL1 3'-UTR are indicated in red. All nucleotides of the seed sequence of the binding site are conserved in several species, including human, mouse, rat and rabbit. The calculated free energy values of the hybrids are indicated. (B) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (C-D) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with miR-125a/b mimic, inhibitor, and scramble negative control. (E-F) Representative blots and relative quantification of MCL1 protein levels in HIEC6 cells transfected with NC mimic, miR-125a mimic or biotinylated miR-125a mimic. (G) qPCR analysis of MCL1 and GAPDH mRNA levels in HIEC6 after pulling down with control probe or miR-125a probe. (H) The relative luciferase activities in HIEC6 transfected with wild type or mutant MCL1 3'-UTR. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Article Snippet: Mammalian MCL1 overexpression plasmids and an empty plasmid (control plasmid) were purchased from Genescript (China). siRNA designed to specifically silence MCL1 and scrambled siRNA (control siRNA) were purchased from RioboBio.

Techniques: Binding Assay, Sequencing, Transfection, Negative Control, Quantitative Proteomics, Control, Luciferase, Mutagenesis

MCL1 promoted proliferation and inhibited apoptosis of HIEC6 cells. (A) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (B-C) Representative blots and relative quantification of MCL1 protein in HIEC6 cells transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (D) CCK-8 were performed 12, 24, 36, 48 and 60 h after the transfection of HIEC6 with MCL1 siRNA, Control siRNA, MCL1 plasmid, or Control plasmid. (E) Representative images of EdU staining in HIEC6 transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (C) Quantitative assessment of percentage of EdU positive cells in (F). (G) Representative flow cytometry plots showing the percentages of early apoptotic cells (Annexin V + /PI - ), late apoptotic cells (Annexin V + /PI + ) and total (early+late) apoptotic cells in HIEC6 transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (H) Pooled flow cytometry data from (G). (I) Representative blots of PCNA and Cleaved C3 protein levels in HIEC6 transfected with MCL1 siRNA, Control siRNA, MCL1 plasmid, or Control plasmid. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Journal: Theranostics

Article Title: Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

doi: 10.7150/thno.41802

Figure Lengend Snippet: MCL1 promoted proliferation and inhibited apoptosis of HIEC6 cells. (A) qPCR analysis of MCL1 mRNA levels in HIEC6 cells transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (B-C) Representative blots and relative quantification of MCL1 protein in HIEC6 cells transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (D) CCK-8 were performed 12, 24, 36, 48 and 60 h after the transfection of HIEC6 with MCL1 siRNA, Control siRNA, MCL1 plasmid, or Control plasmid. (E) Representative images of EdU staining in HIEC6 transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (C) Quantitative assessment of percentage of EdU positive cells in (F). (G) Representative flow cytometry plots showing the percentages of early apoptotic cells (Annexin V + /PI - ), late apoptotic cells (Annexin V + /PI + ) and total (early+late) apoptotic cells in HIEC6 transfected with MCL1 plasmid, Control plasmid, MCL1 siRNA, or scrambled Control siRNA. (H) Pooled flow cytometry data from (G). (I) Representative blots of PCNA and Cleaved C3 protein levels in HIEC6 transfected with MCL1 siRNA, Control siRNA, MCL1 plasmid, or Control plasmid. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Article Snippet: Mammalian MCL1 overexpression plasmids and an empty plasmid (control plasmid) were purchased from Genescript (China). siRNA designed to specifically silence MCL1 and scrambled siRNA (control siRNA) were purchased from RioboBio.

Techniques: Transfection, Plasmid Preparation, Control, Quantitative Proteomics, CCK-8 Assay, Staining, Flow Cytometry

miR-125a inhibited HIEC6 cell proliferation and promoted apoptosis by targeting MCL1. (A-B) Pilot study to determine the dosage of MCL1 vector to rescue miR-125a mimic induced MCL1 suppression. (C) CCK-8 were performed 12, 24, 36, 48 and 60 h after the co-transfection of HIEC6 with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (D) Representative images of EdU staining in HIEC6 cells transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (E) Quantitative analysis of percentage of EdU positive cells in (D). (F-G) Representative flow cytometry plots and relative quantification of the ratio of early apoptotic cells (Annexin V + /PI - ), late apoptotic cells (Annexin V + /PI + ) and total (early late) apoptotic cells in HIEC6 transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (H) Gene expression profiles of proliferation marker PCNA and Ki67 mRNA levels in HIEC6 transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (I) Gene expression profiles of anti-apoptotic Bcl-2 and pro-apoptotic Bax mRNA levels in HIEC6 cells transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Journal: Theranostics

Article Title: Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

doi: 10.7150/thno.41802

Figure Lengend Snippet: miR-125a inhibited HIEC6 cell proliferation and promoted apoptosis by targeting MCL1. (A-B) Pilot study to determine the dosage of MCL1 vector to rescue miR-125a mimic induced MCL1 suppression. (C) CCK-8 were performed 12, 24, 36, 48 and 60 h after the co-transfection of HIEC6 with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (D) Representative images of EdU staining in HIEC6 cells transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (E) Quantitative analysis of percentage of EdU positive cells in (D). (F-G) Representative flow cytometry plots and relative quantification of the ratio of early apoptotic cells (Annexin V + /PI - ), late apoptotic cells (Annexin V + /PI + ) and total (early late) apoptotic cells in HIEC6 transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (H) Gene expression profiles of proliferation marker PCNA and Ki67 mRNA levels in HIEC6 transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. (I) Gene expression profiles of anti-apoptotic Bcl-2 and pro-apoptotic Bax mRNA levels in HIEC6 cells transfected with NC mimic+control vector, miR-125a mimic+control vector, NC mimic +MCL1 vector, miR-125a mimic+MCL1 vector. N=3, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Article Snippet: Mammalian MCL1 overexpression plasmids and an empty plasmid (control plasmid) were purchased from Genescript (China). siRNA designed to specifically silence MCL1 and scrambled siRNA (control siRNA) were purchased from RioboBio.

Techniques: Plasmid Preparation, CCK-8 Assay, Cotransfection, Control, Staining, Transfection, Flow Cytometry, Quantitative Proteomics, Gene Expression, Marker

GLP-2 exerted its intestinotrophic effect by decreasing exosomal miR-125a/b and thus upregulating MCL1 expression in vivo . (A-B) Representative blots and relative quantification of MCL1 protein level in jejunum mucosa of SBS rats treated with GLP-2 or Saline. (C) qPCR analysis of MCL1 mRNA levels in jejunum mucosa of SBS rats treated with GLP-2 or Saline. (D) Representative images of H&E staining, Ki67 staining and TUNEL staining of remaining jejunum in Sham, SBS+NC loaded IMF-Exo and SBS+miR-125a loaded IMF-Exo rats. (E) Quantification of intestinal epithelial thickness in (D). (F) Quantitative analysis of percentage of Ki67 positive cells in (D). (G) Quantitative analysis of percentage of TUNEL positive cells in (D). N=5-8, **p < 0.01, ***p < 0.001.

Journal: Theranostics

Article Title: Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

doi: 10.7150/thno.41802

Figure Lengend Snippet: GLP-2 exerted its intestinotrophic effect by decreasing exosomal miR-125a/b and thus upregulating MCL1 expression in vivo . (A-B) Representative blots and relative quantification of MCL1 protein level in jejunum mucosa of SBS rats treated with GLP-2 or Saline. (C) qPCR analysis of MCL1 mRNA levels in jejunum mucosa of SBS rats treated with GLP-2 or Saline. (D) Representative images of H&E staining, Ki67 staining and TUNEL staining of remaining jejunum in Sham, SBS+NC loaded IMF-Exo and SBS+miR-125a loaded IMF-Exo rats. (E) Quantification of intestinal epithelial thickness in (D). (F) Quantitative analysis of percentage of Ki67 positive cells in (D). (G) Quantitative analysis of percentage of TUNEL positive cells in (D). N=5-8, **p < 0.01, ***p < 0.001.

Article Snippet: Mammalian MCL1 overexpression plasmids and an empty plasmid (control plasmid) were purchased from Genescript (China). siRNA designed to specifically silence MCL1 and scrambled siRNA (control siRNA) were purchased from RioboBio.

Techniques: Expressing, In Vivo, Quantitative Proteomics, Saline, Staining, TUNEL Assay